SUBSCRIBE
SUBSCRIBE
News   Drug Development

AstraZeneca PLC (JOBS), Sanofi (France) (JOBS), Merck & Co., Inc. Heart Drugs Cut Alzheimer’s Disease

January 14, 2010 | 
1 min read
Bookmark and Share

Bloomberg -- Drugs commonly used to lower blood pressure, sold by AstraZeneca Plc, Sanofi-Aventis SA and Merck & Co., may also reduce the risk of developing Alzheimer’s disease.
Clinical research Phase 3 Postmarket research
AstraZeneca Merck & Co. Sanofi
MORE ON THIS TOPIC
Big fish eats small, takeover of the company. Art collage.
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
 · 
2 min read
 · 
Gabrielle Masson
3d rendering of a red and silver realistic model of a retro rocket stands crashed into a wooden desk on a blue background. Failed launch. Technological progress. Technical mistake.
Duchenne muscular dystrophy
Entrada crashes as Duchenne therapy comes in ‘below expectations’ in early study
May 7, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Fibrosis, IPF and the search for better therapies
May 7, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
white dominoes stand in row on mirror surface with double six leading the way.
Business
CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026
May 6, 2026
 · 
1 min read
 · 
Gabrielle Masson